Iverguard Tablets: Uses, Strengths, and Safety
Written by Elizabeth Chernoby in TheSkyMeds Editorial Standards
Medically reviewed by Jonathan Reed, Medical Content Reviewer Sept 11 2026
Iverguard Tablets are oral antiparasitic medicines containing ivermectin, a prescription drug used for selected infections caused by parasites. Depending on the diagnosis and country-specific guidance, ivermectin may be used for conditions such as strongyloidiasis and onchocerciasis, while oral ivermectin is also used for scabies in several countries and clinical guidelines. Iverguard Tablets are sold in different strengths, which does not mean that a higher-strength tablet is more effective or appropriate for every person. Ivermectin dosing is usually determined by body weight, the infection being treated, and relevant medical factors rather than by choosing a tablet strength independently. The medicine can also cause important adverse effects or interact with other treatment, making self-medication inappropriate. This guide explains the verified Iverguard strengths, medically recognized uses of ivermectin, major safety precautions, and what to check before taking the medicine.
What Are Iverguard Tablets?
Iverguard is a brand of ivermectin tablets marketed in India. Ivermectin belongs to a group of medicines called anthelmintics or antiparasitic medicines and acts against certain worms and other parasites.
The brand should not be confused with veterinary ivermectin. Human ivermectin tablets are formulated and dosed for people, while veterinary ivermectin products can contain different concentrations and formulations and should never be taken by humans. The U.S. FDA has reported hospitalizations after people used ivermectin products intended for animals.
What strengths of Iverguard are available?
Current manufacturer information verifies Iverguard tablets containing 3 mg and 6 mg of ivermectin, while a manufacturer-labelled Iverguard-12 carton verifies a 12 mg formulation. The Fortune Healthcare Iverguard product listings identify Iverguard 3 mg and Iverguard 6 mg as ivermectin tablets.
Some online pharmaceutical sellers also advertise Iverguard 15 mg. However, I could not independently confirm that strength from the manufacturer's main product listing or an Indian regulatory source during this review. Anyone supplied with a 15 mg product should therefore verify the manufacturer, licence information, packaging, batch details, and prescription with a pharmacist rather than relying only on an online seller listing.
Iverguard tablet strengths that could be verified from available sources
Iverguard strength | Active ingredient | Verification context | Practical meaning |
Iverguard 3 mg | Ivermectin 3 mg | Listed by manufacturer | Lower tablet strength that can allow weight-based dosing combinations |
Iverguard 6 mg | Ivermectin 6 mg | Listed by manufacturer | Another manufacturer-listed presentation |
Iverguard 12 mg | Ivermectin 12 mg | Verified on manufacturer-labelled product documentation | Higher-strength tablet; not automatically appropriate because a patient weighs more or has more severe symptoms |
Iverguard 15 mg | Advertised as ivermectin 15 mg by some sellers | Not independently confirmed from the primary manufacturer listing used for this review | Verify the exact pack and prescription before purchase or use |
A tablet's strength tells you how many milligrams of ivermectin it contains. It does not tell you how many tablets a particular person should take.
Ivermectin is commonly prescribed according to body weight and the parasite being treated. Choosing between 3 mg, 6 mg, 12 mg, or another advertised strength without calculating the medically appropriate regimen can lead to under-treatment or excessive exposure.
What Are Iverguard Tablets Used For?
The medically appropriate uses of Iverguard depend on the established uses of oral ivermectin and the jurisdiction in which it is prescribed. Strongyloidiasis and onchocerciasis are established indications in U.S. oral-ivermectin labeling, while scabies is another important clinical use supported by international guidance even though its regulatory approval status differs between countries.
Strongyloidiasis
Strongyloidiasis is an infection caused by the roundworm Strongyloides stercoralis. The parasite can live in the intestine for years and may cause abdominal symptoms, rash, cough, or sometimes no obvious symptoms.
Ivermectin is considered first-line treatment for uncomplicated acute and chronic strongyloidiasis in current CDC guidance. The CDC clinical guidance for Strongyloides infection identifies ivermectin as the first-line treatment, with treatment decisions adjusted for situations such as pregnancy, low body weight, or possible Loa loa infection.
Strongyloidiasis becomes particularly important in people who are immunosuppressed. CDC information updated in 2026 notes that hyperinfection and disseminated strongyloidiasis can become life-threatening, particularly in people receiving high-dose corticosteroids.
Onchocerciasis or river blindness
Onchocerciasis is caused by the parasitic worm Onchocerca volvulus and can affect the skin and eyes. Ivermectin acts primarily against the immature worms, called microfilariae.
It does not reliably kill the adult O. volvulus worms. This is why treatment strategies for onchocerciasis differ from those for many short-lived parasitic infections, and repeat treatment may be necessary under specialist or public-health guidance.
People who may also have Loa loa infection require particular caution because severe neurological reactions can occur after microfilaricidal treatment in patients with high Loa loa parasite levels. This issue is mainly relevant to people who live in or have travelled through specific regions of Central and West Africa.
Scabies
Scabies is caused by the human itch mite rather than by an intestinal worm. Oral ivermectin is widely used for scabies in clinical practice and is approved for this purpose in some countries, although regulatory status differs internationally.
Current CDC guidance on oral ivermectin for scabies states that oral ivermectin and topical permethrin have similar efficacy for classic scabies. CDC also notes that oral ivermectin is not FDA-approved for scabies in the United States, illustrating why the approved indication should always be checked for the relevant country.
Oral ivermectin has limited activity against scabies eggs, which is one reason repeat treatment is commonly required when a clinician chooses it for scabies. Crusted scabies is more complicated and generally requires both oral and topical treatment.
Other parasitic infections
Ivermectin is also used in selected circumstances for infections such as cutaneous larva migrans and may appear in guidelines for some soil-transmitted helminth infections. However, the appropriate medicine and regimen depend strongly on the parasite.
A tablet labelled “antiparasitic” should therefore not be taken for any suspected worm infection without identifying what is actually being treated. Albendazole, mebendazole, pyrantel, ivermectin, and other medicines do not cover exactly the same parasites.
How Are Iverguard Strength and Dose Determined?
Iverguard strength and ivermectin dose are not the same thing. Strength is the amount of ivermectin in one tablet, while the prescribed dose is the total amount a patient needs for a particular treatment, often calculated from body weight.
For example, official U.S. ivermectin labeling uses weight-based regimens for strongyloidiasis and onchocerciasis. The label describes approximately 200 micrograms per kilogram for intestinal strongyloidiasis and approximately 150 micrograms per kilogram for onchocerciasis.
These figures explain how medical dosing is structured; they are not instructions to calculate and take Iverguard without a prescription.
Why ivermectin dosing can differ between conditions
Treatment situation | General evidence-based dosing principle | Important limitation |
Intestinal strongyloidiasis | Commonly weight-based | Diagnosis and follow-up may be needed; severe or disseminated disease requires a different treatment approach |
Onchocerciasis | Weight-based treatment with repeat treatment determined clinically or through public-health programmes | Ivermectin targets microfilariae but does not eliminate adult worms |
Classic scabies | Weight-based oral treatment is commonly repeated because ivermectin has limited activity against mite eggs | Regulatory approval differs by country; pregnancy and children under 15 kg require particular caution |
Crusted scabies | Multiple ivermectin doses may be combined with topical treatment | Requires clinician-directed treatment because severity and schedules vary |
Other parasites | Regimen depends on the exact organism | Ivermectin is not the preferred treatment for every worm infection |
Why shouldn't you choose the dose from body weight alone?
Body weight is only one part of prescribing. The diagnosis, severity, repeat-dose requirements, age, pregnancy or breastfeeding status, liver health, other medicines, and potential exposure to particular parasites can change what is appropriate.
Even eating instructions can differ by indication. Standard oral-ivermectin labeling commonly instructs patients to take tablets with water on an empty stomach, while CDC scabies guidance notes that scabies experts recommend ivermectin with food to improve bioavailability for that particular use.
That is another reason not to use a generic internet dosing rule for every ivermectin treatment.
What Side Effects and Safety Risks Can Ivermectin Cause?
Most people receiving an appropriate ivermectin dose do not develop severe toxicity, but side effects can occur and some reactions require medical attention. The type of parasite being treated can also influence symptoms because inflammatory reactions may occur as parasites die.
Reported effects can include:
dizziness;
headache;
nausea;
diarrhoea;
abdominal discomfort;
tiredness or weakness;
itching or skin rash; and
temporary light-headedness or low blood pressure in some circumstances.
For onchocerciasis, some reactions occur because large numbers of microfilariae are killed. These inflammatory responses can produce itching, rash, swelling, fever, swollen lymph nodes, joint or muscle discomfort, or low blood pressure.
Can ivermectin affect the brain or nervous system?
Serious neurological toxicity is uncommon but has been reported. Current prescription labeling includes postmarketing reports of altered consciousness, marked drowsiness, confusion, disorientation, stupor, coma, and death.
Excessive doses can increase risk. The FDA also reports that ivermectin overdose can cause dizziness, loss of coordination, seizures, low blood pressure, coma, and death.
Do not take extra tablets because symptoms persist, and do not repeat a dose earlier than directed.
Can ivermectin interact with other medicines?
Yes. Medication interactions are possible, which is why a clinician or pharmacist should know what else you take.
FDA consumer guidance specifically notes that ivermectin can interact with medicines such as blood thinners. CDC scabies guidance also identifies potential interactions that may influence treatment selection.
Bring an updated list of prescription medicines, over-the-counter products, and supplements when ivermectin is prescribed.
Who Should Be Especially Careful With Iverguard Tablets?
Pregnancy, breastfeeding, very low body weight, certain parasitic exposures, and significant medical illness deserve particular consideration before ivermectin is used. The safety question is not simply whether ivermectin is “safe” in general but whether its expected benefit outweighs its risks for a specific patient and infection.
Pregnancy and breastfeeding
Human pregnancy data remain limited. CDC guidance states that ivermectin's use during pregnancy requires balancing the risk from the infection against the uncertainty surrounding treatment. WHO excludes pregnant women from ivermectin mass-treatment campaigns because adequate safety information is lacking.
Ivermectin is present in human milk in low concentrations. Treatment while breastfeeding should therefore be discussed with the prescribing clinician rather than started independently.
Children under 15 kg
Current WHO and CDC information continues to note that ivermectin safety has not been adequately established in children weighing less than 15 kg.
This weight threshold is more useful than assuming that every child above or below a particular age can take the medicine.
Possible Loa loa infection
People with substantial Loa loa infection can experience dangerous neurological complications after ivermectin. This is primarily relevant to people who have lived in or travelled through Loa loa-endemic parts of Africa.
For that reason, CDC lists confirmed or suspected Loa loa coinfection as a relative contraindication when treating Strongyloides and advises assessment for Loa loa before ivermectin treatment of onchocerciasis where appropriate.
Be careful about where the tablets come from
Medicine quality and authenticity matter as much as the ingredient printed on the carton. Buy prescription ivermectin through a legitimate licensed pharmacy and check that the strength, manufacturer, batch, expiry date, and packaging match the prescription.
There is a brand-specific reason to take sourcing seriously. In 2024, Australia's Therapeutic Goods Administration analysed one sample represented as Iverguard-12. That particular sample contained ivermectin but failed the laboratory's assay specification and content-uniformity requirement. The TGA laboratory certificate for the tested Iverguard-12 sample documents an ivermectin assay of 88.4% against a stated USP requirement of 90–110%.
This finding applies to the specific sample tested and does not establish that every Iverguard product is substandard. It does, however, reinforce the importance of obtaining medicine through regulated supply channels rather than unfamiliar online exporters or unverified sellers.
How Should Iverguard Tablets Be Used Safely?
Use Iverguard only for the infection and regimen prescribed. Do not copy somebody else's dose, use a veterinary preparation, increase the number of tablets because symptoms seem severe, or assume that a stronger tablet is more effective.
Practical safety points include:
Confirm the diagnosis rather than treating an unexplained rash or digestive symptom as “worms.”
Check the active ingredient and tablet strength every time the medicine is supplied.
Follow the prescriber's instructions on dose timing, food, and repeat treatment.
Tell the prescriber about pregnancy, breastfeeding, liver disease, neurological illness, and all other medicines.
Do not use an animal ivermectin formulation.
Do not take ivermectin specifically to prevent or treat COVID-19; the FDA states that ivermectin is not authorized or approved for that purpose and currently available clinical-trial data do not demonstrate effectiveness.
Store the tablets according to the manufacturer's packaging and keep medicines away from children.
If the pack or tablets look different from what you were previously supplied, ask a pharmacist to verify them before use.
When Should You Seek Medical Advice or Urgent Care?
Contact a healthcare professional if you are not sure what infection you have, symptoms continue after treatment, or a repeat ivermectin dose is being considered without a clear treatment plan. Persistent symptoms do not necessarily mean that another tablet is needed.
Seek urgent medical care after ivermectin if you develop severe confusion, loss of consciousness, a seizure, major difficulty walking or coordinating movements, severe weakness, breathing difficulty, facial or throat swelling, a serious widespread rash, or other rapidly worsening symptoms.
For scabies, continued itching alone does not necessarily mean treatment has failed. CDC notes that itching may continue for several weeks after successful therapy, while new burrows, new pimple-like lesions, or symptoms persisting beyond the expected period may require reassessment.
People receiving corticosteroids or other significant immunosuppressive treatment should also tell their clinician about possible previous exposure to Strongyloides. Severe Strongyloides hyperinfection can occur in immunosuppressed patients and requires urgent medical management.
Conclusion
Iverguard Tablets contain ivermectin, an antiparasitic medicine with established roles in selected infections such as strongyloidiasis and onchocerciasis and recognized clinical use for scabies in appropriate patients. Verified Iverguard presentations include 3 mg, 6 mg, and 12 mg tablets, but tablet strength should never be used to choose a dose independently because ivermectin treatment is often weight- and diagnosis-specific.
Use ivermectin only from a reliable pharmacy and according to a clinician's instructions. Pregnancy, children under 15 kg, potential Loa loa exposure, other medicines, and severe or persistent symptoms deserve particular medical attention. Consult a doctor or pharmacist if your prescribed strength, treatment schedule, or product authenticity is unclear.
Frequently Asked Questions
1. What are Iverguard Tablets used for?
Iverguard contains ivermectin, an antiparasitic medicine. Oral ivermectin has established uses for infections including intestinal strongyloidiasis and onchocerciasis and is also used for scabies under appropriate clinical guidance. The exact indication and regulatory approval can differ between countries.
2. What strengths does Iverguard come in?
Manufacturer information verifies Iverguard 3 mg and 6 mg, while manufacturer-labelled documentation verifies Iverguard-12 containing 12 mg ivermectin. Some sellers advertise a 15 mg version, but this could not be independently confirmed from the primary manufacturer listing used for this review, so verify the pack.
3. Is Iverguard 12 mg stronger than Iverguard 6 mg?
Yes, a 12 mg tablet contains twice as much ivermectin as a 6 mg tablet. However, “stronger” does not mean better or more effective for an individual patient. Ivermectin dosage depends on factors including body weight, diagnosis, and the prescribed treatment schedule.
4. Can Iverguard be used for scabies?
Oral ivermectin is an established treatment option for scabies in several guidelines and countries. In the United States, oral ivermectin is used for scabies but is not FDA-approved specifically for that indication. A clinician should determine whether oral ivermectin or a topical treatment is appropriate.
5. Is ivermectin safe during pregnancy or for small children?
Safety data are insufficient for routine ivermectin use during pregnancy and in children weighing under 15 kg. WHO and CDC guidance therefore recommend particular caution in these groups. A clinician should weigh the risks of the infection against available treatment alternatives.
6. Can I take Iverguard for COVID-19?
Ivermectin should not be self-used to prevent or treat COVID-19. The U.S. FDA states that ivermectin is not authorized or approved for COVID-19 and that currently available clinical-trial data do not demonstrate effectiveness for this purpose. Large or inappropriate doses can also cause serious toxicity.
Comments